Cargando…

PB1953: ASSESSMENT OF THE EFFICACY OF BORTEZOMIB-CONTAINING THERAPY REGIMENS DEPENDING ON MAGE-C1 GENE EXPRESSION IN MULTIPLE MYELOMA PATIENTS.

Detalles Bibliográficos
Autores principales: Eleonora, M., Larisa, M., Vadim, S., Maxim, S., Maia, F., Irina, G., Sergey, K., Anton, S., Elisabeth, M., Alexandra, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431582/
http://dx.doi.org/10.1097/01.HS9.0000850648.81507.c0
_version_ 1784780094509678592
author Eleonora, M.
Larisa, M.
Vadim, S.
Maxim, S.
Maia, F.
Irina, G.
Sergey, K.
Anton, S.
Elisabeth, M.
Alexandra, A.
author_facet Eleonora, M.
Larisa, M.
Vadim, S.
Maxim, S.
Maia, F.
Irina, G.
Sergey, K.
Anton, S.
Elisabeth, M.
Alexandra, A.
author_sort Eleonora, M.
collection PubMed
description
format Online
Article
Text
id pubmed-9431582
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-94315822022-08-31 PB1953: ASSESSMENT OF THE EFFICACY OF BORTEZOMIB-CONTAINING THERAPY REGIMENS DEPENDING ON MAGE-C1 GENE EXPRESSION IN MULTIPLE MYELOMA PATIENTS. Eleonora, M. Larisa, M. Vadim, S. Maxim, S. Maia, F. Irina, G. Sergey, K. Anton, S. Elisabeth, M. Alexandra, A. Hemasphere Publication Only Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9431582/ http://dx.doi.org/10.1097/01.HS9.0000850648.81507.c0 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Publication Only
Eleonora, M.
Larisa, M.
Vadim, S.
Maxim, S.
Maia, F.
Irina, G.
Sergey, K.
Anton, S.
Elisabeth, M.
Alexandra, A.
PB1953: ASSESSMENT OF THE EFFICACY OF BORTEZOMIB-CONTAINING THERAPY REGIMENS DEPENDING ON MAGE-C1 GENE EXPRESSION IN MULTIPLE MYELOMA PATIENTS.
title PB1953: ASSESSMENT OF THE EFFICACY OF BORTEZOMIB-CONTAINING THERAPY REGIMENS DEPENDING ON MAGE-C1 GENE EXPRESSION IN MULTIPLE MYELOMA PATIENTS.
title_full PB1953: ASSESSMENT OF THE EFFICACY OF BORTEZOMIB-CONTAINING THERAPY REGIMENS DEPENDING ON MAGE-C1 GENE EXPRESSION IN MULTIPLE MYELOMA PATIENTS.
title_fullStr PB1953: ASSESSMENT OF THE EFFICACY OF BORTEZOMIB-CONTAINING THERAPY REGIMENS DEPENDING ON MAGE-C1 GENE EXPRESSION IN MULTIPLE MYELOMA PATIENTS.
title_full_unstemmed PB1953: ASSESSMENT OF THE EFFICACY OF BORTEZOMIB-CONTAINING THERAPY REGIMENS DEPENDING ON MAGE-C1 GENE EXPRESSION IN MULTIPLE MYELOMA PATIENTS.
title_short PB1953: ASSESSMENT OF THE EFFICACY OF BORTEZOMIB-CONTAINING THERAPY REGIMENS DEPENDING ON MAGE-C1 GENE EXPRESSION IN MULTIPLE MYELOMA PATIENTS.
title_sort pb1953: assessment of the efficacy of bortezomib-containing therapy regimens depending on mage-c1 gene expression in multiple myeloma patients.
topic Publication Only
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431582/
http://dx.doi.org/10.1097/01.HS9.0000850648.81507.c0
work_keys_str_mv AT eleonoram pb1953assessmentoftheefficacyofbortezomibcontainingtherapyregimensdependingonmagec1geneexpressioninmultiplemyelomapatients
AT larisam pb1953assessmentoftheefficacyofbortezomibcontainingtherapyregimensdependingonmagec1geneexpressioninmultiplemyelomapatients
AT vadims pb1953assessmentoftheefficacyofbortezomibcontainingtherapyregimensdependingonmagec1geneexpressioninmultiplemyelomapatients
AT maxims pb1953assessmentoftheefficacyofbortezomibcontainingtherapyregimensdependingonmagec1geneexpressioninmultiplemyelomapatients
AT maiaf pb1953assessmentoftheefficacyofbortezomibcontainingtherapyregimensdependingonmagec1geneexpressioninmultiplemyelomapatients
AT irinag pb1953assessmentoftheefficacyofbortezomibcontainingtherapyregimensdependingonmagec1geneexpressioninmultiplemyelomapatients
AT sergeyk pb1953assessmentoftheefficacyofbortezomibcontainingtherapyregimensdependingonmagec1geneexpressioninmultiplemyelomapatients
AT antons pb1953assessmentoftheefficacyofbortezomibcontainingtherapyregimensdependingonmagec1geneexpressioninmultiplemyelomapatients
AT elisabethm pb1953assessmentoftheefficacyofbortezomibcontainingtherapyregimensdependingonmagec1geneexpressioninmultiplemyelomapatients
AT alexandraa pb1953assessmentoftheefficacyofbortezomibcontainingtherapyregimensdependingonmagec1geneexpressioninmultiplemyelomapatients